MT-6402

N/A

Report date: 2024/11/05 20:00:08

Base Information

Drug NameMT-6402
Drug Alias NameMT-6402MT-64-6402
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Programmed death-ligand 1Apoptosis stimulantsCytotoxic T lymphocytes stimulants +[4] 
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Templates Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Templates Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck

Other Information

ATC CodeN/A
Related LinksN/A